Ipamorelin is a selective growth hormone secretagogue that activates the ghrelin receptor (GHS-R) in the pituitary
Overall, results from the cardiovascular outcomes trials (CVOTs) completed for all marketed GLP-1 RAs in type 2 diabetes support a benefit in HF specifically in addition to the approved use in broad CVD risk reduction in people with type 2 diabetes (Sattar et al., 2021)
HbA1c, which indicates a three-month average glucose exposure, follows long-term changes
Rohayem J, Alexander EC, Heger S, Nordenstrom A, Howard SR
Most research peptides reconstitute at concentrations between 1-5mg/ml depending on the specific compound and research protocol requirements
South Florida patients have an added environmental challenge